| Financial Year |
March 31 2023 |
| Monetary Funds |
542,250,586.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
156,960,875.59 |
| Accounts Receivable |
236,155,952.46 |
| Advances to Suppliers |
76,667,316.32 |
| Other Receivables |
17,461,567.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,925,341.20 |
| Inventories |
1,103,569,076.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,358,891.99 |
| Total Current Assets |
2,665,262,428.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,850,530.43 |
| Investment Properties |
4,082,191.92 |
| Fixed Assetes |
1,036,571,427.72 |
| Under-construction Projects |
25,644,380.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,070,047.25 |
| R&D expenses |
-- |
| Goodwill |
28,444,631.86 |
| Long-Term Deferred and Prepaid Expenses |
1,540,073.76 |
| Deferred Income Tax Assets |
20,390,050.21 |
| Other Non-Current Assets |
62,839,600.62 |
| Sub-Total of Non-Current Assets |
1,874,718,277.01 |
| Total Assets |
4,539,980,705.12 |
| Short-Term Loans |
508,702,778.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
72,386,120.00 |
| Accounts Payable |
313,246,497.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,852,458.71 |
| Taxes Payable |
13,432,270.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,298,867.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
93,813,630.58 |
| Other Current Liabilities |
21,252,353.97 |
| Sub-Total of Current Liabilities |
1,126,883,517.59 |
| Long-term Loans |
92,950,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
33,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
42,550,262.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
281,839,173.72 |
| Total Liabilities |
1,408,722,691.31 |
| Paid-In Capital(Or Share Stock) |
742,082,425.00 |
| Capital Surplus |
1,463,112,961.75 |
| Surplus Reserve |
101,768,814.37 |
| LESS:Treasury Stock |
64,510,416.00 |
| Undistributed Profits |
825,128,802.25 |
| Minority Stockholder's Interest |
51,305,684.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,079,952,329.49 |
| Owner's Equity（Stockholder's Equity） |
3,131,258,013.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,539,980,705.12 |
